A final consideration is that, as mTOR and PPARγ are involved in many metabolic processes, it is highly likely that comorbidities including diabetes and obesity, nutrition and ageing will have profound consequences on the effect of targeting these pathways effectively and safely.
That is, interventions in the diabetes population were mostly more cost-effective than in the general population reflecting the effect of targeting to a high risk group.
In the present study, we evaluated the effect of targeting PI3K-Akt-mTOR signaling pathway, to identify effective strategies to improve therapeutic outcome when radiotherapy and TMZ are used concurrently to treat GBM.
Inhibition of this feedback loop with various PI3K/AKT signaling inhibitors facilitated the effect of targeting p38γ MAPK.
Nevertheless there is still a room for optimisation in the area of the nanoparticle kinetics such as improving their plasma circulation and tumour bioavailability and understanding the effect of targeting ligands on their efficiency to treat cancer.
We next tested the effect of targeting PRL-3 on ABT-869-mediated cytotoxicity.
The effect of targeting sTEVp to the membrane on cleavage of cytosolic C34V was investigated (Fig. 5Bi, right).
Next, we tested the effect of targeting in situ recipient's splenic DCs with donor apoptotic cells on development of CAV in a model of aortic allografts.
Since, both BRAF and CRAF signal through their effectors MEK1 and MEK2, we sought to understand the effect of targeting MEKs in IPC298 cells.
We used a mathematical model to evaluate optimal pH1N1 vaccination strategies, focusing our analysis on the Canadian population and considering the effect of targeting different age groups for prioritization of vaccine allocation on projected hospitalizations and mortality.
Given that BRAF, CRAF, BRAF+CRAF and MEK1+2 double knock-down had an adverse effect on HCT116 cell proliferation and tumor growth, we examined the effect of targeting these genes on cell cycle progression.
